Big Pharma strikes back with data secrecy [Off Topic]

posted by mittyri – Russia, 2019-10-28 11:13 (1638 d 15:39 ago) – Posting: # 20727
Views: 4,221
(edited by mittyri on 2019-10-28 12:59)

Hi all,

Some EMA news

If the Court of Justice upholds the view that CSRs [clinical study reports] should benefit from a general presumption of confidentiality, it would change the rules of the game. Sadly, such a move could easily take us back to a situation where disclosure of clinical trial data is the exception, instead of being the norm.

See here
—
Kind regards,
Mittyri

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,663 registered users;
33 visitors (0 registered, 33 guests [including 8 identified bots]).
Forum time: 03:53 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5